Healthcare ❯ Pharmaceutical Industry ❯ Drug Development

GLP-1 Medications

Orforglipron Market Trends

Eli Lilly Picks Huntsville for $6 Billion API Plant to Supply Next-Gen Drugs

The move advances onshoring of active ingredients to support orforglipron within Lilly’s $27 billion U.S. buildout.

Pfizer Closes Metsera Buyout, Adding GLP-1 Assets in Cash-Plus-CVR Deal